Back to search

Article

Quantitative G6PD point-of-care test can be used reliably on cord blood to identify male and female newborns at increased risk of neonatal hyperbilirubinaemia: a mixed method study

2022-07-05

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Introduction</h4> New point-of-care (POC) quantitative G6PD testing devices developed to provide safe radical cure for P. vivax malaria may be used to diagnose G6PD deficiency in newborns at risk of severe neonatal hyperbilirubinaemia, improving clinical care, and preventing related morbidity and mortality. <h4>Methods:</h4> We conducted a mixed-methods study analyzing technical performance a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c7067015-df78-53d8-a652-fae768a8ad6d
DOI
10.1101/2022.07.03.22277173
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Quantitative G6PD point-of-care test can be used reliably on cord blood to identify male and female newborns at increased risk of neonatal hyperbilirubinaemia: a mixed method studyDOI 10.1101/2022.07.03.22277173
Diagnostic performances of the fluorescent spot test for G6PD deficiency in newborns along the Thailand-Myanmar border: A cohort studySemantic proximity
Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.Semantic proximity
Diagnostic accuracy of the Point-of-Care Standard G6PD test™ (SD Biosensor) for Glucose-6-phosphate dehydrogenase deficiency: a systematic review of the literatureSemantic proximity
Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in MauritaniaSemantic proximity
Newborn screening of glucose-6-phosphate dehydrogenase deficiency in Guangxi, China: determination of optimal cutoff value to identify heterozygous female neonates.Semantic proximity
High levels of pathological jaundice in the first 24 hours and neonatal hyperbilirubinaemia in an epidemiological cohort study on the Thailand-Myanmar border.Semantic proximity
Molecular genotyping of G6PD mutations for neonates in Ningbo area.Semantic proximity
Glucose-6-phosphate dehydrogenase (G6PD)-deficient infants: Enzyme activity and gene variants as risk factors for phototherapy in the first week of life.Semantic proximity
Revised World Health Organization (WHO) classification of G6PD gene variants: Relevance to neonatal hyperbilirubinemia.Semantic proximity
Screening results and mutation frequency analysis of G6PD deficiency in 1,291,274 newborns in Huizhou, China: a twenty-year experience.Semantic proximity
Newborn Screening Fact SheetsSemantic proximity
Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.Semantic proximity
Select a neighboring publication to make it the new centre.